Sarah Hogan > McDermott Will & Emery LLP > Boston, United States > Lawyer Profile

McDermott Will & Emery LLP
28 STATE STREET
BOSTON, MA 02109-1775
United States
Sarah Hogan photo

Work Department

Healthcare

Position

Partner Sarah Hogan represents companies in the life sciences and digital health industries on structuring and negotiating intellectual property licenses, strategic collaborations and other complex commercial transactions – helping her clients leverage intellectual property assets and collaborate to develop and deliver innovative solutions that improve health and health care. Sarah uses her science background and comprehensive life sciences industry knowledge as an asset to understand critical business concerns and effectively manage complex issues. As a result of the diverse range of clients and transactions she manages, Sarah has in-depth understanding of the implications of each deal on various aspects of the business, including downstream transactions. Sarah is known for her practical approach – focusing on achieving business objectives while balancing legal risks and preserving her clients’ relationship with their partners.

Sarah regularly advises clients on the following transactions: license and collaboration transactions to develop and commercialize pharmaceutical and medical device products; cross-industry collaborations, joint development arrangements and joint ventures for products in the convergence of health, technology and life sciences.

For further details of Sarah’s biography, please view McDermott website:
https://www.mwe.com/people/hogan-sarah-t/

Lawyer Rankings

United States > Industry focus > Healthcare: life sciences

McDermott Will & Emery LLP‘s patent litigators William (Bill) Gaede in Silicon Valley and Sarah Columbia in Boston have been acting for Amgen in a patent lawsuit brought by the client against Sanofi and Regeneron and alleging the defendants’ patent infringement of Amgen’s patents to antibody therapies designed to lower cholesterol. The client base also includes 23andMe and Allergan. Other key members of the team are Chicago-based Kristian Werling, who co-heads the practice with Boston’s Stephen Bernstein; Washington DC-based Paul Radensky, who specializes in regulatory and reimbursement matters; IP and commercial transactions expert Sarah Hogan in Boston; FDA regulatory practitioner Vernessa Pollard in Washington DC; and Roger Kuan from the San Francisco office, which was opened in March 2018.

United States > Media, technology and telecoms > Technology transactions

Dallas-based Shawn C. Helms and Jason D. Krieser jointly head the team at McDermott Will & Emery LLP, which advises on outsourcing, licensing and cloud computing arrangements in the telecoms, IT, healthcare, social media and e-commerce sectors. Other contacts include David Guedry and Heather S. Bethancourt, also in Dallas, and Sarah T. Hogan, who practices in the firm’s Boston office. Highlights have included advising Monsanto on an application development deal in connection with an IT outsourcing transaction, and acting for Baxalta in a research development collaboration with Precision BioSciences concerning the development and commercialization of a T-cell therapy. Other clients have included Motorola, Xerox Corporation and Finnair.